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Endurance run increases circulating IL-6 and IL-lra 
but downregulates ex vivo TNF-a and IL-lß production
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Drenth, Joost P. H., Stan H. M. Van Uum, Marcel 
Van Deuren, Gerard J . Pesman, Johanna Van Der Ven- 
Jongekrijg, and Jos W. M. Van Der Meer. Endurance run 
increases circulating IL-6 and IL-lra but downregulates ex 
vivo TNF-a and IL -lß  production. J. Appl. Physiol. 79(5): 
1497-1503, 1995.—We investigated whether a 6-h endur­
ance run changes cytokine plasma concentrations and lipo- 
polysaccharides (LPS) stimulated ex vivo production of cyto­
kines in a whole blood culture of 19 well-trained athletes. 
The average distance covered was 65.1 ± 8.64 (SD) km. At 
the end of the exercise, the mean plasma concentration of 
interleukin-l-receptor agonist (IL-lra), which was 188 pg/ml 
24 h before finish, increased to 886 pg/ml (P < 0.0005). The 
mean plasma interleukin-6 concentration increased from 
18.5 ± 4.2 to 71.5 ± 33.3 pg/ml {P < 0.0001). The increase 
of neutrophils correlated with the increase of IL-lra concen­
trations (r = 0.58, P < 0.005). We could not detect an effect 
of exercise on plasma concentrations of interleukin-lß  (IL- 
l ß ) or tumor necrosis factor-a (TNF-a). The ex vivo LPS- 
stimulated production of IL -lß  in athletes 24 h before the run 
was significantly higher than in sedentary controls. Exercise 
induced a decrease of LPS-stimulated production of IL -lß  
and TNF-a, whereas production of IL-lra was unchanged. 
These results show that prolonged exercise elicits a selective 
downregulation of the proinflammatory cytokine production 
and upregulation of the cytokines IL-lra and interleukin-6.
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PROINFLAMMATORY CYTOKINES such as tumor necrosis
factor-a (TNF-a:), interleukin (IL)-l, IL-6, and the anti­
inflammatory IL-1-receptor antagonist (IL-lra) are in­
volved in various immunologic and inflammatory pro­
cesses (38). In this respect, there are indications that 
physical exercise modifies plasma cytokine concentra­
tion and its production. Early studies indicated that 
plasma IL-1 bioactivity increases after exercise (6), but 
this was not confirmed in later studies using immuno­
assays (29, 33, 36). For example, a 20-km run did not 
influence the plasma immunoreactive concentrations 
of IL-lß , TNF-a:, and IL-6 in well-trained runners, al­
though the urinary secretion of these cytokines was 
temporarily increased just after exercise (33). The ef­
fect of physical exercise on ex vivo production of cyto­
kines by blood cells has not been studied extensively, 
and results are rather conflicting. When using isolated 
monocytes, Rivier et al. (30) noted a modest increase of 
spontaneous TNF-a production after exercise, whereas 
Haahr et al. (20) found no such difference after lipo- 
polysaccharide (LPS) stimulation. ^ 
We therefore decided to study the effect of intense 
prolonged exercise (6-h run) on plasma concentrations
of IL - lß , IL-6, TNF-a, and IL-lra and ex vivo produc­
tion (using a whole blood culture system) of IL-lß, 
TNF-a:, and IL-lra.
MATERIALS AND METHODS
Exercise protocol and human subjects. A total of 73 athletes 
(71 men and 2 women) entered a 6-h endurance run competi­
tion on October 16,1994, in Geldrop, The Netherlands. Thirty 
participants were asked by telephone, in the weeks before 
the run, to join the proposed study. Finally, 21 well-trained 
long-distance male athletes (mean age 43.7 ± 8.4 yr, range 
26-59 yr) participated in our study. These volunteers are 
regularly involved in long-distance running competitions. 
The ambient temperature at that day was 12°C, with a hu­
midity of 70%. The wind velocity was 5.5 m/s. After explana­
tion of the aims of the study, written informed consent was 
obtained from all participants. The participants refrained 
from exercise in the 24-h period before the first test. The 
study was approved by the Ethical Committee of the St. Jo­
seph Hospital in Veldhoven, The Netherlands.
Blood samples. Blood samples were drawn from the ante- 
cubital vein at rest in a sitting position 24 h before the pro­
jected end of the run (to correct as much as possible for circa­
dian effects) and immediately after end of the exercise. Blood 
for cytokine measurements was collected into 4-ml (circulat­
ing) and 2-ml (ex vivo production) endotoxin-free EDTA tubes 
(Vacutainer Systems, Becton and Dickinson, Rutherford, 
NJ). The plasma was immediately processed to avoid ex vivo 
cytokine production and release (11). Cytokine production 
was measured using a whole blood culture system as de­
scribed elsewhere (39). Briefly, two 2-ml tubes containing 24 
¿¿1 EDTA-K.3 (10,000 kallikrein-inactivating units/ml; Bayer, 
Leverkusen, Germany) were drawn.
One tube was incubated immediately, the other was incu­
bated after addition of 25 /il LPS {Escherichia coli serotype 
055:B5; Sigma Chemical, St Louis, MO; final concentration 
10 [i%!ml blood). After 24 h of incubation at 37°C, both tubes 
were centrifuged at 2,250 g  for 10 min and then at 15,000 g 
for 5 min to obtain platelet-poor plasma. Aliquots were stored 
at -70°C until assay. Hemoglobin, leukocyte numbers, and 
differential counts before and after the run were determined 
with an automated Coulter counter STKS (Coulter Electron­
ics Hialeah FI).
Source of antiserum. Polyclonal antibodies for IL -lß  were 
kindly provided by Sciavo (Siena, Italy), and antibodies for 
TNF-a: were a gift of Dr. C. A. Dinarello (New England Medi­
cal Center, Boston, MA). A polyclonal anti-IL-lra antiserum 
was raised in New Zealand White rabbits immunized with 
human recombinant IL-lra kindly provided by Synergen 
(Boulder, CO).
Radiolabeling of cytokines. Human recombinant IL-1/? and 
TNF-a: were radiolabeled by using the chloramine-T method 
(37). Briefly, 5 /ig IL -lß  or TNF-a in 10 pi of 0.5 M phosphate 
buffer, pH 7.4, and 18.5 MBq Na12:)I (Amersham Interna­
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tional, UK) and 4 //I chloramine T (8.9 mmol/1) were added 
to the tubes and incubated for 10 s. The reaction was termi­
nated by adding 20 ¿/I Na2S20 5 (26.3 mmol/1) in 0.25 M phos­
phate buffer.
Human recombinant IL-lra was radiolabeled with 125I by 
the method of Bolton and Hunter (5). In short, 0.28 f j g  of 
Bolton-Hunter reagent (0.1 /¿g///l) was radioiodinated with 
37 MBq 125I by adding 5 fjg NCS ( 1 /¿g///l) as a reductor during 
10 min at room temperature. The reaction was stopped after 
the addition of 5 f u g  Na2S20 5 as an oxidator. The mixture was 
evaporated to dryness during ~1 h under a stream of N2, 
and subsequently 4 fjg IL-lra (5 //g//xl) in 1.0 M bicarbonate 
buffer, pH 8.2, were added and incubated for 15 min at 0°C. 
After the labeling reactions, the reaction mixtures were ap­
plied to a Sephadex G-25 column (PD-10; Pharmacia, Upp­
sala, Sweden) and eluted with phosphate-buffered saline 
(PBS) (IL-1/5 and TNF-a) or 0.25% gelatine in PBS (IL-lra) 
to separate labeled proteins from free 12 T.
Radioimmunoassay (RIA) for cytokines. IL-lß, TNF-a, and 
IL-lra in plasma were measured in duplicate by nonequilib­
rium RIA. Recombinant human IL-1/5, TNF-a, and IL-lra 
were calibrated against standards provided by the National 
Institute of Biological Standards and Control (Potters Bar, 
UK). The RIA was performed as follows. One hundred micro­
liters of rabbit polyclonal cytokine antibodies (final dilution 
of IL -lß  1:210,000; TNF-a 1:150,000; and IL-lra 1:60,000, 
giving a binding with tracer of ~25%), dissolved in RIA buffer 
per liter containing 13 mM Na2 EDTA, 0.02% sodium azide,
0.25%' bovine serum albumin (Behring, Marburg, Germany),
0.1% Triton X-100 3 mM Na2H • PO.,, and 250,000 kallikrein- 
inactivating units aprotinine, pH 7.4 (Bayer, Leverkussen, 
Germany), were added to sample and standard. All reagents 
were prepared with this buffer. For circulating cytokine mea­
surement, 100 [i 1 of sample and standard were added, and 
for measurement of ex vivo cytokine production, 25 //I (TNF- 
a) and 10 fj\ (IL-lß and IL-lra) of sample and standard were 
added. The mixture was incubated for 1 day at room tempera­
ture. Subsequently, tracer (=^7,000 dpm/100 //l) was added, 
and incubation was continued for another 2 days.
To separate bound and free tracer from the free fraction, 
100 fj\ of a separation agent [10% (vol/vol) sheep anti-rabbit 
immunoglobulin G and 0.01% (wt/vol) rabbit immunoglobulin 
G (Sigma, St. Louis, MO)] were added to each tube and incu­
bated for 30 min at room temperature. The antibody complex 
was completely precipitated by the addition of 1 ml 7.5% 
polyethylene glycol 6000 (Merck, Darmstadt, Germany). For 
IL-lß, TNF-a, and IL-lra, the range of the standard curve 
was 20-3,000 pg/ml. The sensitivity of the assay with 100- 
/il sample was 60 pg/ml (IL-lra), 40 pg/ml (IL-lß), and 20 
pg/ml (TNF-a). To minimize analytic errors, all samples from 
the same patient were analyzed in the same run in duplicate.
In our assay for IL-lß, with complete specific precipitation 
of the first antibody with the second antibody, chloroform 
extraction for eliminating interfering factors is not needed 
(9). Samples treated with chloroform extraction showed a 
good correlation to those without treatment (r = 0.77). The 
interference of soluble interleukin-1 receptors (sILr) with the 
measurement of IL-lß has not actually been tested in this 
assay. The recovery, however, of IL-lß with this assay is 
70%. The linearity, as tested by addition of two samples with 
unknown IL-lß content to a sample with established IL-lß 
concentration, gave a correlation coefficient of 0.99. A fine 
parallelism has been shown for IL-lß (r = 0.90) for sample 
volumes from 3 up to 100 //l. For TNF-a, this RLA measures 
total TNF-a (both free and complexed to its receptors), as 
demonstrated by the lack of interference of the addition up to
5 ng/ml recombinant soluble tumor necrosis factor receptors
(sTNFr) (p55 and p75) to sera containing known amounts of 
TNF-a (4). The recovery of TNF-a in our RIA was estimated 
at 93.3% However, no satisfying parallelism was achieved 
with TNF-a with this assay. To avoid this problem, sample 
volumes were adjusted for measurement of circulating TNF- 
a (100 /jl) and ex vivo production (25 /il), and with these 
quantities accurate intragroup comparison of results was 
possible.
For IL-lra, the recovery was estimated at 86.2%. Good 
parallelism is achieved with native human IL-lra reagents. 
With human recombinant IL-lra, complete parallelism is 
lacking and only measurements from fixed amounts of sam­
ple can be compared. Therefore, the sample volume for mea­
surement of circulating IL-lra is 100 /A, compared with 10 
fjl for assessment of ex vivo production. To correct for sponta­
neous ex vivo cytokine production, we calculated the net LPS- 
stimulated production according to the following formula: net 
cytokine production = production with LPS - production 
without LPS.
The interassay variation of our RIA is estimated at <15%, 
whereas the intra-assay variation is <10%, which are typical 
results for these assays.
Control values for cytokine ex vivo production were ob­
tained at a given day from 10 healthy sedentary volunteers 
(20-45 yr of age). These values were 6,847 ± 2,175 pg/ml 
(IL-lß); 3,344 ± 969 pg/ml (TNF-a), and 9,827 ± 2,597 pg/ml 
(IL-lra). Very similar concentrations were found in samples 
drawn from the same volunteers 24 h later.
Enzyme-linked immunosorbent assay (ELISA) for IL-6. IL- 
6 was measured with an ELISA (Central Laboratory of the 
Netherlands Red Cross Blood Transfusion Service, Amster­
dam, the Netherlands) as follows (21). Flat-bottom microtiter 
plates were coated for 24 h at room temperature with anti- 
IL-6 monoclonal antibody (diluted 1:100 in coating buffer). 
The plates were washed five times with PBS containing
0.005% Tween 20 and were incubated for 1 h with PBS con­
taining 5% bovine serum albumin (Sigma Chemical A.7030) 
to prevent aspecific binding. Subsequently, the plates were 
washed five times with washing buffer, and samples (100 /il) 
were added.
After incubation for 1 h at 37°C, the plate was again 
washed five times, and biotinylated sheep antibody to human 
IL-6 in conjugate buffer (100 /A) was added to the wells and 
incubated for 1 h longer at 37°C. After five more washes, 
streptavidin horseradish peroxidase conjugate (diluted 
1:10,000) was added and the plate was incubated for 30 min 
at room temperature. After the samples were washed again 
five times, 100 fj\ of substrate (2,2-amino-bis C3-ethylbenz- 
thiazoline sulfonic acid, pH 4.0) were added, and after 30- 
min incubation at room temperature the color reaction was 
terminated with 100 ¡A 2% oxalic acid. The optical density 
was read at 450 nm with a Titertek Multiskan ELISA reader 
(Eflab, Oy, Helsinki, Finland). The sample values were com­
pared with a standard curve; the lower limit of detection with 
this assay is 14 pg/ml. There is no interference of sIL-6r in
the IL-6 ELISA.
Statistical analysis. The paired nonparametric Wilcoxon 
signed-rank test was used for statistical comparison of values 
obtained before and after physical exercise. Probability (P) 
values were calculated on the basis of two-tailed tests. A 
correlation coefficient was calculated with the Pearson’s cor­
relation test. A P  < 0.05 was considered to be the lowest level 
of significance. Data are given in mean ± SD.
RESULTS
Exercise. The average distance covered by the ath­
letes was 65.1 ± 8.6 km (range 51.7-86.2 km). Two
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TABLE 1. Total leukocytes and differential leukocyte 
count
Parameter Preexercise Postexercise
Total leukocytes 7.3±1.6 16.7+4.1
Neutrophils 4.4±1.3 14.5±3.9
Monocytes 0.55±0.1 0.98±0.4
Lymphocytes 2.1±0.6 1.1±0.3
Values are means ± SD, expressed in X l09/1; n = 19 for every 
group. Postexercise values differ significantly (P < 0.0005) from pre­
exercise values for each parameter listed.
athletes did not complete the 6-h run because of minor 
injuries. They were excluded from the analysis.
Blood cells. The 6-h endurance run resulted in a sig­
nificant (P < 0.0005) increase in total leukocytes (2.3- 
fold), neutrophils (3.4-fold), and monocytes (1.8-fold) 
(Table 1). The lymphocyte count was reciprocally de­
creased (P < 0.0005). There was a moderate positive 
correlation between covered distance and leukocytosis
(r = 0.47, P < 0.05).
Circulating cytokines. As shown in Figure 1, A  and
B, there was no effect of exercise on the plasma concen­
trations of IL -lß  and TNF-a. The plasma IL-lra con­
centration increased fivefold during exercise, compared 
with preexercise values, from 188 ± 72 to 886 ± 395 
pg/ml (median 855 pg/ml, range 290-1,450 pg/ml) (P <
0.0005) (Fig. 1C). The mean plasma IL-6 concentration 
increased from 18.5 ± 4.2 to 71.5 ± 33.3 pg/ml (median 
64 pg/ml, range 24-130 pg/ml) immediately after the 
6-h run (P < 0.0001) (Fig. ID). A positive correlation 
was observed between the postexercise plasma concen­
trations of IL-lra and TNF-a (r = 0.57, P < 0.0005), 
of IL-lra and IL-6 (r = 0.61, P < 0.005), and of IL-6 
and TNF-a (r = 0.48, P < 0.05). A correlation between 
postexercise values of IL-lß and IL-lra was absent. 
The increase of neutrophils did correlate with the in­
crease of IL-lra concentrations (r = 0.58, P < 0.005).
Ex vivo production of cytokines. Before exercise, ex 
vivo LPS-stimulated netto production of IL-lß in whole 
blood culture from athletes was significantly higher 
than that of sedentary controls (P < 0.0005) (Fig. 2). 
The preexercise LPS-stimulated production of TNF-a 
and IL-lra did not differ between athletes and controls.
Before the run, only for TNF-a a moderate positive 
correlation of age with LPS-stimulated production 
could be detected (r = 0.045, P = 0.025). This positive 
correlation disappeared after the endurance run.
After exercise, the LPS-stimulated production of 
TNF-a and IL-lß decreased appreciably (P < 0.0005) 
(Fig. 2). The IL-lra production did not change signifi­
cantly. The LPS-stimulated production of TNF-a corre­
cted with that of IL-lß (r = 0.89, P < 0.0001).
DISCUSSION
This study shows that a 6-h endurance run leads to 
a fivefold increase of plasma IL-lra concentrations and 
an almost fourfold increase of IL-6 concentrations in 
very well-trained individuals, which suggests that pro­
longed exercise leads to an inflammatory reaction in
humans. IL-lra is a naturally occurring inhibitor of IL-
1 and is able to block its biological activities (14). IL- 
lra is synthesized in humans in response to a variety 
of inflammatory stimuli and appears to limit the delete­
rious effects of IL-1. In vitro, a number of stimuli ap­
pear to induce mononuclear cells to produce IL-lra in 
great excess over IL-la and IL-lß. After experimental 
endotoxin challenge and during infection, large 
amounts of IL-lra are found in the circulation com­
pared with only minor quantities of IL-1 (18, 19, 24). 
It has been established that strenuous exercise leads 
to an acute phase response with neutrophilia, mono­
cytosis, and elevation of acute phase proteins such as 
C-reactive protein and fibrinogen (22, 41). IL-lß, TNF-
a, and IL-6 are regarded as major inducers of this re­
sponse in humans (2). In our study, plasma concentra­
tions of TNF-a and IL-lß did not change in relation 
to exercise but we found significant elevations of IL-6 
concentrations. These findings are in accordance with 
other studies in which increased IL-6 concentrations 
could be measured after prolonged duration exercise 
(28, 33, 36). There are indications that the kinetics of 
IL-6 depend on the duration of exercise, since normal­
ization of IL-6 plasma values occurred at 2 h after a 1- 
h ergometer cycle test at 75% of maximal 0 2 uptake 
but only at 24 h after a 20-km run, which took some 
110 min (33, 36). Our finding of unchanged TNF con­
centrations is in line with those from several investiga­
tors (30, 32, 33, 36). In contrast with our results, how­
ever, other have reported increased TNF-a concentra­
tions in well-conditioned runners after a 5-km run (16) 
and after a 2.5-h run (15). One explanation for this 
discrepancy could be that we missed an increase of 
TNF-a concentrations because we sampled immedi­
ately after the exercise, whereas Dufeaux and Order 
(15) and Espersen et al. (16) detected significant in­
creases of TNF-a at, respectively, 1 and 2 h after the 
end of the exercise. These investigators did not detect 
significant increases immediately after the run either 
(15, 16). A second explanation for this discrepancy is 
that the increase of TNF concentration is rather short 
lived, like in experimental endotoxin challenge, and 
occurred earlier. Therefore, we might have missed the 
TNF-a elevations. Our inability to detect an increase 
of TNF-a does not seem to be due to counterregulation 
by shedding of TNF receptors in the blood, since our 
RIA detects both free and soluble receptor-bound TNF 
(4). It is also unlikely that our assay is too insensitive 
to detect a relevant TNF-a peak, because we have per­
formed control procedures as illustrated by the ade­
quate recovery of exogeneous cytokines added in pico- 
gram concentrations to plasma. Furthermore, the 125I 
tracers used in our study were freshly made, ensuring 
specific binding and optimal sensitivity. Additional ex­
planations could be the variations in the physical condi­
tion of the volunteers, duration as well as the degree 
of exercise between the various studies.
With regard to IL-1, there is more controversy. An 
elevated baseline IL-1 bioactivity has been reported in 
highly trained endurance runners (17), and exercise is 
associated with enhanced IL-1 bioactivity (6). Other
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f i g . 1. Circulating interleukin (IL)-lß (A), tumor necrosis factor (TNF-a; B), IL-1 receptor antagonist (IL-lra; 
C), and IL-6 (D ) in 19 athletes. Individual values are represented by black dots and were obtained 24 h before 
projected end of and immediately after a 6-h endurance run. Bars indicate means ± SD. Increase was statistically 
significant for IL-lra (P < 0.0005) and IL-6 (P < 0.0001).
studies using ELISA (27, 35) and, like in our study, 
radioimmunometric assays, failed to find an effect of 
exercise on plasma IL -lß  concentrations. This discrep­
ancy could be due to the fact that the mouse thymocyte
bioassay does not distinguish between IL-la , IL-lß, 
and IL-6 (41). Indeed, we and others noted elevated IL- 
6 concentrations in plasma after exercise, which could 
explain the above-mentioned results (28, 33, 36).
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FIG. 2. Production of IL-1/?, TNF-a, and IL-lra in a 
whole blood culture system stimulated with lipopolysac- 
charide (LPS). Data are shown as means ± SD and are 
derived from experiments with 19 athletes immediately 
after (cross-hatched bars) and 24 h before projected end 
of a 6-h endurance run (hatched bars) and in 10 healthy 
sedentary controls (open bars). * P < 0.0005 compared 
with preexercise values in athletes.
IL-1 beta TNF alpha IL-1ra
The LPS-stimulated production of IL -lß  ex vivo at 
baseline from athletes was significantly higher com­
pared with values obtained in our laboratory from 
healthy but sedentary controls. This finding cannot be 
attributed to random temporal changes in cytokine pro­
duction, since no significant differences were detected 
in sedentary controls in blood drawn at 2 consecutive 
days. This suggests that regular training results in an 
enhanced IL -lß  response to LPS exposure in vitro. We 
observed that the 6-h endurance run in these well- 
trained individuals results in a profound decrease of 
LPS-stimulated IL -lß  and TNF-a production in the 
whole blood culture system. A similar loss of production 
capacity of cytokines has been observed in the acute 
stage of several clinical conditions such as sepsis (27), 
typhoid fever (24), and after major surgery (25). In 
studies from our laboratory, this downregulated proin­
flammatory cytokine response was demonstrated to be 
associated with a preserved IL-lra response similar 
to the one we observed in the current study (24, 25). 
However, the present results differ from in vitro stud­
ies in which isolated mononuclear cells were used (20, 
26). In studies of Haahr et al. (20) and Lewicki et al. 
(26), exercise elicited increased IL-1/? concentrations in 
supernatants from LPS-stimulated monocytes. (20, 25) 
In another study, spontaneous release of TNF-a from 
isolated monocytes was slightly increased at the end of 
an incremental exercise test but decreased significantly 
at 20 min after the end of exercise (30). The already 
mentioned results of Haahr et al. (20) did not find that 
exercise had an effect on TNF-a production by LPS- 
stimulated monocytes. Again, there are a number of 
explanations. As indicated before, differences in the 
degree and duration of exercise and training back­
ground of the volunteers may be crucial. In addition, 
the whole blood culture system used in our study is 
somewhat different from culture systems using iso­
lated cells. The whole blood culture system reflects the 
cytokine response of all types of blood cells to a given 
stimulus, and this is less artificial and less susceptible
to unwanted ex vivo stimulation than methods using 
cells isolated by density centrifugation (39).
It is of interest that the downregulation of LPS-stim­
ulated cytokine production is found despite the eleva­
tion of number of monocytes, because these cells are 
considered the major producers of IL -lß  and TNF-a. 
The downregulation in the whole blood cultures could 
be due to a plasma factor. In theory, several factors 
could inhibit cytokine production: cytokines such as 
transforming growth factor-/? (TGF-/?), IL-4, and IL-10 
have been shown to downregulate TNF-a, IL-1/?, and 
IL-6 production from LPS-stimulated isolated mono­
cytes (12, 13, 34). Furthermore, TGF-/?, IL-4, and IL­
IO have been shown to upregulate IL-lra production 
(23, 40). Epinephrine and endogenous glucocorticoids 
are released into the circulation in response to exercise, 
and both compounds inhibit the release of IL-1, IL-6, 
and TNF-a from isolated monocytes (1, 25, 30). It is of 
interest that our ex vivo results are in line with results 
from in vivo experiments with rats, which show that 
exercise before exposure to LPS suppresses the TNF 
response over a period of ~6 h (3). Exercise-induced 
suppression of the LPS-stimulated cytokine response 
may have both detrimental and beneficial conse­
quences. Curtailing the monocyte production of TNF- 
a and IL -lß  may compromise the host defense response 
against invading pathogens on the one hand; on the 
other hand, it may protect against cytokine-mediated 
damage of muscle tissue during and after exercise (7, 
10). The finding of decreased response to LPS ex vivo is 
reminiscent of endotoxin tolerance, i.e., the decreased 
response to a high dose of LPS after pretreatment with 
a low dose of LPS. It has been found that intense exer­
cise such as performed in a thriathlon is associated 
with a 3.6-fold increase of plasma LPS concentrations 
in these athletes, perhaps caused by excessive leakage 
of LPS from the gastrointestinal tract due to reduced 
splanchnic flow (31). Consequently, it may be suggested 
that the downregulation of proinflammatory cytokines 
after exercise is due to endotoxin (18, 19). Further re­
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search is needed to elucidate the mechanism of the 
downregulation of cytokine production after exercise.
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